We Use Cookies

This website uses cookies to optimize performance, preferences, usage and statistics. By accepting them, you consent to store on your device only the cookies that don't require consent. You can check our privacy policy page for more information.

Barriers to results-based contracts

Results-based contracts—also known as value-based contracts—have the potential to lower costs for patients and the health system. Despite the promise of these innovative payment approaches, regulations instituted before innovative contracting approaches were developed can create uncertainty for biopharmaceutical companies looking to pursue these contracts and can discourage them from entering into these beneficial agreements.